Fisher David 4
4 · Enova International, Inc. · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
Enova (ENVA) Exec Chairman David Fisher Exercises Options, Sells Shares
What Happened David Fisher, Executive Chairman and Director of Enova International (ENVA), exercised derivative awards to acquire 33,060 shares (exercise price $20.73/share, total cash paid $685,334) on 2026-06-17 and then sold those 33,060 shares in the open market for an aggregate of approximately $6,580,639 (weighted average sale price $199.05/share). The filing also shows a related derivative listed as disposed at $0, reflecting the tandem SAR/option structure where exercising one instrument cancels the other.
Key Details
- Transaction date: 2026-06-17; Form filed: 2026-06-22 (reporting period 6/17/2026). No late-filing flag noted in the provided extract.
- Exercise: 33,060 shares acquired at $20.73 each (total paid $685,334).
- Sale: 33,060 shares sold in multiple trades; weighted average sale price $199.05 (range $193.85–$202.70), total proceeds ≈ $6,580,639 (footnote F1).
- Related derivative: 33,060 derivative units reported disposed at $0 consistent with a tandem SAR/option arrangement (footnotes F2–F3).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Vesting note: underlying options vested in roughly equal thirds on 2/11/2021, 2/11/2022, and 2/11/2023 (footnote F4).
Context
- This was effectively a cashless exercise followed by an immediate open-market sale (exercise + sale in same date), a common way for insiders to monetize vested options/SARs.
- Footnotes explain the SAR/option were granted in tandem and exercising one causes the other to expire; SAR payout mechanics depend on a qualifying "Offer" and a 30-day average price (see F2–F3).
- The sale reduced insider exposure but, without post-transaction holdings reported here, the remaining ownership stake is not shown in this summary.
Insider Transaction Report
Form 4
Fisher David
DirectorExecutive Chairman
Transactions
- Exercise/Conversion
Common stock, par value $0.00001 per share
2026-06-17$20.73/sh+33,060$685,334→ 339,504 total - Sale
Common stock, par value $0.00001 per share
[F1]2026-06-17$199.05/sh−33,060$6,580,639→ 306,444 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy) with limited SAR
[F2][F3][F4]2026-06-17−33,060→ 213,182 totalExercise: $20.73Exp: 2027-02-11→ Common stock; par value $0.00001 per share (33,060 underlying)
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $193.85 to $202.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
- [F2]The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- [F3]The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- [F4]The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Signature
/s/ Sean Rahilly, as attorney in fact|2026-06-22